You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Low-Latency Embedded Vision Processor (LLEVS)
SBC: Nanowatt Design, Inc Topic: AF15AT13ABSTRACT: The goal of head-worn display systems is to increase situation awareness and reduce operator workload. The urgent need is for higher image resolution and lower system latency, while meeting constraints on head-borne weight and power. Current processor solutions cannot meet increased requirements. The challenge is that power consumption is proportional to the amount of data being handled, ...
STTR Phase I 2015 Department of DefenseAir Force -
Point Source Ozonation to Minimize Antibiotic Resistance
SBC: Biodetection Instruments, Inc Topic: N/ADESCRIPTION (provided by applicant): BluelnGreen, LLC proposes to develop an effective, versatile and cost efficient device for the application of ozone micro-bubbles to the effluent of critical point sources of medical wastewater (hospitals, large clinics and pharmaceutical manufacturing plants) to reduce the overall amount of both antibiotic residuals and resistant pathogens that are released t ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Dendritic cell immunotherapy for ovarian cancer
SBC: Dcv Technologies, Inc. Topic: N/ADESCRIPTION (provided by applicant): The majority of ovarian cancer patients have advanced disease at the time of diagnosis, and ovarian cancer has the highest mortality rate among gynecological malignancies. Immunotherapy based on induction of tumor-specific cytotoxic T lymphocyte (CTL) responses may represent a viable treatment for these patients. The prospects for immunological treatment of can ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Laser Tweezer Based Instrument for Cell Biology Research
SBC: MINOTAUR TECHNOLOGIES, LLC Topic: N/ADESCRIPTION (provided by applicant): The proposed project is to develop an instrument for cell biology research based on a technique for perturbing local cytosolic concentrations of key signal transduction mediators with sustainable submicrometer resolution. In this technique, microspheres are decorated with selected enzymes, creating high local concentrations of an effector at the particle surf ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Feasibility of Dual Use Module for Major Depression
SBC: Psychiatric Assessment Systems Topic: N/ADESCRIPTION (provided by applicant): Each year, only 10-20% of 18.5 million Americans with depression receive appropriate, effective care. Psychiatric Assessment Systems (PAS) seeks to address poor quality of care for this common, debilitating disorder by developing a tool to help psychiatrists more effectively treat patients with depression. Psychiatrists have little incentive now to use clinical ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Magnetohydrodynamic-based Laboratories on a Chip
SBC: VEGRANDIS, LLC Topic: N/ADESCRIPTION (provided by applicant): In this Phase II project, Vegrandis, LLC proposes to develop a magnetohydrodynamic (MHD) microfluidic based "sample-in, answer-out" bioassay chip for diagnosis of ovarian cancer. The proposed bioassay chip will use MHD microfluidics to pump the sample and reagents necessary to perform the assay and will have integrated micro-electrochemical detection of a panel ...
STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Exploiting porcine cytomegalovirus stealth mechanisms
SBC: Xenocept, Inc. Topic: N/ADESCRIPTION (provided by applicant): Pig-to-human xenotransplantation may alleviate the critical shortage of organs available for transplantation. However, hyperacute rejection (HAR), acute vascular rejection (AVR), and cell-mediated rejection pose significant immunological hurdles to making xenotransplantation a clinical reality. Now that pigs lacking a functional alpha-1,3-galactosyltransferase ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
